Viewing Study NCT00002266


Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2026-01-01 @ 1:20 PM
Study NCT ID: NCT00002266
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module